AlphaGalileo53m
Semaglutide Can Have Lifetime Cost and Health Benefits for Non-Diabetic Overweight or Obese Individuals with Heart Disease
For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not ...
Hosted on MSN58m
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...